ES2329354T3 - Derivados de isoquinolina. - Google Patents
Derivados de isoquinolina. Download PDFInfo
- Publication number
- ES2329354T3 ES2329354T3 ES03725018T ES03725018T ES2329354T3 ES 2329354 T3 ES2329354 T3 ES 2329354T3 ES 03725018 T ES03725018 T ES 03725018T ES 03725018 T ES03725018 T ES 03725018T ES 2329354 T3 ES2329354 T3 ES 2329354T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- quad
- benzyloxy
- dihydro
- isoquinolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02009253 | 2002-04-26 | ||
| EP02009253 | 2002-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2329354T3 true ES2329354T3 (es) | 2009-11-25 |
Family
ID=29265896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES03725018T Expired - Lifetime ES2329354T3 (es) | 2002-04-26 | 2003-04-14 | Derivados de isoquinolina. |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6818774B2 (ru) |
| EP (1) | EP1501804B1 (ru) |
| JP (1) | JP4322685B2 (ru) |
| KR (1) | KR100681585B1 (ru) |
| CN (1) | CN1310890C (ru) |
| AR (1) | AR039651A1 (ru) |
| AT (1) | ATE440821T1 (ru) |
| AU (1) | AU2003227614B2 (ru) |
| BR (1) | BR0309562A (ru) |
| CA (1) | CA2483461C (ru) |
| DE (1) | DE60328978D1 (ru) |
| DK (1) | DK1501804T3 (ru) |
| ES (1) | ES2329354T3 (ru) |
| GT (1) | GT200300095A (ru) |
| HK (1) | HK1080836A1 (ru) |
| HR (1) | HRP20040952A2 (ru) |
| IL (1) | IL164677A0 (ru) |
| MX (1) | MXPA04010537A (ru) |
| MY (1) | MY133527A (ru) |
| NO (1) | NO20044571L (ru) |
| NZ (1) | NZ535885A (ru) |
| PA (1) | PA8572001A1 (ru) |
| PE (1) | PE20040594A1 (ru) |
| PL (1) | PL373697A1 (ru) |
| PT (1) | PT1501804E (ru) |
| RU (1) | RU2318812C2 (ru) |
| SI (1) | SI1501804T1 (ru) |
| TW (1) | TWI278451B (ru) |
| UY (1) | UY27786A1 (ru) |
| WO (1) | WO2003091219A1 (ru) |
| ZA (1) | ZA200408281B (ru) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1816544B (zh) * | 2003-05-19 | 2011-06-08 | Irm有限责任公司 | 免疫抑制剂化合物和组合物 |
| CA2524027C (en) * | 2003-05-19 | 2013-03-19 | Irm Llc | Immunosuppressant compounds and compositions |
| MY150088A (en) | 2003-05-19 | 2013-11-29 | Irm Llc | Immunosuppressant compounds and compositions |
| BRPI0413923A (pt) * | 2003-08-29 | 2006-11-07 | Ono Pharmaceutical Co | composto capaz de ligar o receptor de s1p e uso farmacêutico do mesmo |
| CN1874991A (zh) | 2003-08-29 | 2006-12-06 | 小野药品工业株式会社 | 能够结合s1p受体的化合物及其药物用途 |
| CA2543287A1 (en) * | 2003-10-23 | 2005-05-06 | F.Hoffmann-La Roche Ag | Benzazepine derivatives as mao-b inhibitors |
| CN1926109B (zh) | 2004-03-01 | 2011-04-13 | 埃科特莱茵药品有限公司 | 经取代的1,2,3,4-四氢异喹啉衍生物 |
| ATE541830T1 (de) | 2004-12-13 | 2012-02-15 | Ono Pharmaceutical Co | Aminocarbonsäurederivat und dessen medizinische verwendung |
| WO2006079622A2 (de) * | 2005-01-28 | 2006-08-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur herstellung von isochroman und derivaten davon |
| KR20070094666A (ko) | 2005-02-25 | 2007-09-20 | 에프. 호프만-라 로슈 아게 | 약제 물질 분산성이 향상된 정제 |
| BRPI0620239B8 (pt) | 2005-12-22 | 2021-05-25 | Newron Pharm Spa | derivados de 2-feniletilamino. |
| US20090082394A1 (en) * | 2006-03-15 | 2009-03-26 | Actelion Pharmaceuticals, Ltd. | Tetrahydroisoquinoline Derivatives to Enhance Memory Function |
| WO2007122591A2 (en) | 2006-04-26 | 2007-11-01 | Actelion Pharmaceuticals Ltd | Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists |
| KR101220182B1 (ko) * | 2009-02-25 | 2013-01-11 | 에스케이바이오팜 주식회사 | 치환된 아졸 유도체 화합물, 이를 포함하는 약제학적 조성물 및 이를 이용한 파킨슨씨 병 치료방법 |
| CN105315204B (zh) * | 2014-07-04 | 2018-02-09 | 中南大学 | 7‑氨基‑1,4‑二氢异喹啉‑3(2h)‑酮衍生物及其合成方法和用途 |
| CN105461626B (zh) * | 2015-12-17 | 2018-05-08 | 浙江工业大学 | 芳环或稠杂环联3,4-二氢异喹啉类共轭结构化合物及其应用 |
| CN105585527B (zh) * | 2015-12-17 | 2018-06-26 | 浙江工业大学 | 2-(3,4-二氢异喹啉-1(2h)-亚基)乙腈类化合物及其应用 |
| WO2018183171A1 (en) * | 2017-03-27 | 2018-10-04 | Bristol-Myers Squibb Company | Substituted isoquionline derivatives as immunomudulators |
| CN114591238B (zh) * | 2022-03-25 | 2022-11-15 | 邦恩泰(山东)生物医药科技集团股份有限公司 | 一种异喹啉类药物中间体的合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5731324A (en) * | 1993-07-22 | 1998-03-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| IL110172A (en) * | 1993-07-22 | 2001-10-31 | Lilly Co Eli | Bicycle compounds and pharmaceuticals containing them |
| US6137002A (en) * | 1993-07-22 | 2000-10-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| US6448269B1 (en) * | 1993-07-22 | 2002-09-10 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| US5679715A (en) | 1995-06-07 | 1997-10-21 | Harris; Richard Y. | Method for treating multiple sclerosis |
| AU709323B2 (en) | 1996-03-15 | 1999-08-26 | Somerset Pharmaceuticals, Inc. | Method for preventing and treating peripheral neuropathy by administering selegiline |
| WO2001034172A2 (en) | 1999-11-05 | 2001-05-17 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
-
2003
- 2003-04-14 KR KR1020047017185A patent/KR100681585B1/ko not_active IP Right Cessation
- 2003-04-14 PL PL03373697A patent/PL373697A1/xx unknown
- 2003-04-14 WO PCT/EP2003/003845 patent/WO2003091219A1/en active Application Filing
- 2003-04-14 RU RU2004134575/04A patent/RU2318812C2/ru not_active IP Right Cessation
- 2003-04-14 BR BR0309562-2A patent/BR0309562A/pt not_active IP Right Cessation
- 2003-04-14 CA CA2483461A patent/CA2483461C/en not_active Expired - Fee Related
- 2003-04-14 SI SI200331658T patent/SI1501804T1/sl unknown
- 2003-04-14 NZ NZ535885A patent/NZ535885A/en not_active IP Right Cessation
- 2003-04-14 MX MXPA04010537A patent/MXPA04010537A/es active IP Right Grant
- 2003-04-14 EP EP03725018A patent/EP1501804B1/en not_active Expired - Lifetime
- 2003-04-14 ES ES03725018T patent/ES2329354T3/es not_active Expired - Lifetime
- 2003-04-14 AT AT03725018T patent/ATE440821T1/de not_active IP Right Cessation
- 2003-04-14 CN CNB038093766A patent/CN1310890C/zh not_active Expired - Fee Related
- 2003-04-14 DK DK03725018T patent/DK1501804T3/da active
- 2003-04-14 JP JP2003587782A patent/JP4322685B2/ja not_active Expired - Fee Related
- 2003-04-14 PT PT03725018T patent/PT1501804E/pt unknown
- 2003-04-14 DE DE60328978T patent/DE60328978D1/de not_active Expired - Lifetime
- 2003-04-14 AU AU2003227614A patent/AU2003227614B2/en not_active Ceased
- 2003-04-16 US US10/417,378 patent/US6818774B2/en not_active Expired - Fee Related
- 2003-04-23 TW TW092109478A patent/TWI278451B/zh not_active IP Right Cessation
- 2003-04-23 PA PA20038572001A patent/PA8572001A1/es unknown
- 2003-04-24 GT GT200300095A patent/GT200300095A/es unknown
- 2003-04-24 PE PE2003000408A patent/PE20040594A1/es not_active Application Discontinuation
- 2003-04-24 AR ARP030101412A patent/AR039651A1/es unknown
- 2003-04-25 MY MYPI20031578A patent/MY133527A/en unknown
- 2003-04-28 UY UY27786A patent/UY27786A1/es not_active Application Discontinuation
-
2004
- 2004-10-12 HR HR20040952A patent/HRP20040952A2/hr not_active Application Discontinuation
- 2004-10-13 ZA ZA200408281A patent/ZA200408281B/xx unknown
- 2004-10-18 IL IL16467704A patent/IL164677A0/xx not_active IP Right Cessation
- 2004-10-22 NO NO20044571A patent/NO20044571L/no not_active Application Discontinuation
-
2006
- 2006-01-13 HK HK06100541A patent/HK1080836A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2329354T3 (es) | Derivados de isoquinolina. | |
| ES2314219T3 (es) | Derivados de cinamida. | |
| US5869511A (en) | Isoxazoline compounds as inhibitors of TNF release | |
| RU2336268C2 (ru) | Производные 4-пирролидинофенилбензилового эфира | |
| ES2322254T3 (es) | Fluorobenzamidas apropiadas para el tratamiento de la enfermedad de alzheimer o demencia senil. | |
| ES2344454T3 (es) | Derivados de arilalquilcarbamatos, su preparacion y su aplicacion en terapeutica. | |
| ES2270154T3 (es) | Derivados de 3h-quinazolin-4-ona. | |
| ES2324214T3 (es) | Derivados de n-acilaminobenceno como inhibidores de la monoamina oxidasa b selectiva. | |
| CA2477771A1 (en) | Phthalimido derivatives as inhibitors of monoamine oxidase b | |
| AU2005250124B2 (en) | Butyrylcholinesterase selective inhibitors | |
| RU2392267C2 (ru) | Ингибиторы моноаминоксидазы (мао-в) | |
| ES2314877T3 (es) | Metodo para preparar derivados de eter-4-pirrolidino-fenilbencilico enantiomericamente puros. | |
| US5252747A (en) | Chiral quinolone intermediates | |
| US6846832B2 (en) | 2,3-dihydro-isoindol-1-one derivatives | |
| AU2003255334B2 (en) | 2,3-dihydro-isoindol-1-ones with MAO-B inhibiting activity | |
| KR20070031959A (ko) | 선택적 부티릴콜린에스테라제 저해제 |